AIIMS-Delhi is reportedly unable to find enough number of volunteers for the Phase 3 trials of Covaxin, a coronavirus vaccine candidate being developed by Bharat Biotech and ICMR. AIIMS officials have observed people are unwilling to participate in the trials thinking a vaccine would anyway be available soon.

The All India Institute of Medical Sciences (AIIMS) in Delhi is one of the sites conducting the final phase of the trial of Covaxin and it needs around 1,500 volunteers.

"We wanted 1,500-2,000 participants but so far, we have been able to recruit only around 200 participants. People are unwilling to participate in the exercise thinking why take part in a trial when a vaccine would be available soon for everyone," Dr Sanjay Rai, professor at AIIMS and also the principal investigator of the study, said.

Meanwhile, with focussed strategy and proactive as well as calibrated measures of the Union Government along with the States and UTs, India has sustained a very high Recovery Rate along with rapidly declining  Active Cases and low mortality rate.

Recoveries outnumbering new cases on a daily basis have ensured a high recovery rate among patients. The total recovered cases are nearing 95 lakh(94, 89,740). The Recovery Rate has improved to 95.31% today. The gap between Recovered cases and Active cases is also increasing consistently and presently stands at 91,67,374.

The rising recoveries have also led to a continuous contraction of India’s Active Caseload. It has ensured that India’s present active caseload of 3,22,366 consists of just 3.24%of India’s Total Positive Cases.